Anti-Anginal (Non-Nitrate)Conditionally Approved

Ranolazine

Brand names: Ranexa|Last verified: 2026-03-01

FAA Pathway: Special Issuance required — coronary artery disease evaluation mandatory

Ranolazine requires Special Issuance evaluation. Used as second-line angina therapy, the underlying coronary disease must be thoroughly documented. The medication itself has QT prolongation risk.

Check your medications

Look up any medication in our FAA compatibility database.

Medication Checker

Pilot Tip

Always report all medications on your FAA medical application (Form 8500-8, Item 17a), even OTC medications. Failure to disclose is a far bigger issue than the medication itself.

Certification Details

Key Requirements
Cardiac evaluation, ECG monitoring for QT prolongation
Certificate Classes
Depends on coronary disease severity
Notes
Newer anti-anginal — FAA experience still growing

Sources

  • FAA AME Guide, Cardiology

Last verified: 2026-03-01

Frequently Asked Questions

Is Ranolazine allowed for pilots?

The FAA considers Ranolazine (Ranexa) to be "Conditionally Approved" for medical certification purposes. Ranolazine requires Special Issuance evaluation. Used as second-line angina therapy, the underlying coronary disease must be thoroughly documented. The medication itself has QT prolongation risk.

What is the FAA status of Ranolazine?

Ranolazine has a status of "Conditionally Approved" under FAA medical certification policy. The certification pathway is: Special Issuance required — coronary artery disease evaluation mandatory.

Can I fly while taking Ranolazine?

Flying while taking Ranolazine may be possible through the FAA's Special Issuance process. You will need to meet specific requirements and obtain approval before exercising pilot privileges. Consult an experienced AME for guidance.

Important Notice

The FAA does not publish a comprehensive list of “approved” medications. The information on this page represents our interpretation of publicly available FAA guidance and is provided for informational and educational purposes only. It does not constitute medical advice, legal advice, or a guarantee of certification outcome.

The primary issue with the FAA is always whether the underlying medical condition — not just the medication — is compatible with safe flight. You should only start, stop, or change medications after consulting your treating physician. Always consult with a qualified Aviation Medical Examiner (AME) for guidance specific to your situation. FAA policies are subject to change. ClearedMed is not affiliated with or endorsed by the FAA.